Acuamark Diagnostics Announces Addition Of David C. Weavil To Its Board Of Directors
NEW YORK--(BUSINESS WIRE)--Acuamark Diagnostics, Inc., a biotechnology company that focuses on developing accurate and cost-effective blood-based screening tests for the early detection of cancer, today announced the addition of David C. Weavil to its Board of Directors.
Mr. David C. Weavil is a seasoned industry executive with over thirty years of experience in the diagnostics industry, and has a track record of successfully running and growing both public and private laboratory companies.
Mr. David C. Weavil is a seasoned industry executive with over thirty years of experience in the diagnostics industry, and has a track record of successfully running and growing both public and private laboratory companies.